Development and validation of dependence and craving measures specific to athletes who use anabolic-androgenic steroids.

Barnaby N Zoob Carter, Ian D Boardley
Author Information
  1. Barnaby N Zoob Carter: School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom.
  2. Ian D Boardley: School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom.

Abstract

Background: Anabolic-androgenic steroid (AAS) dependence affects approximately 30% of people who use AAS. Presently, measures to assess and diagnose AAS dependence are adapted from scales specific to other forms of drug misuse (e.g., alcohol), containing issues with internal consistency and breadth of construct capture. Additionally, there are no measures available to assess AAS craving, which represents a potentially important coeval factor to AAS dependence. Therefore, this study aimed to develop and provide evidence of validity for measures of AAS dependence and AAS craving.
Methods: Data were collected from male and female strength athletes who use AAS across two samples ( ���=���206; ���=���224). Sample 1 completed the new measures alongside instruments assessing theoretically related constructs (Doping Moral Disengagement, Doping Self-Regulatory Efficacy Scale, craving items from the Wisconsin Smoking Withdrawal Scale, AAS adapted Diagnostic and Statistical Manual for Mental Disorder 4 Edition), whereas Sample 2 completed the new instruments.
Results: Exploratory and Confirmatory Factor Analyses (CFA) with Sample 1 data were used to finalize the item sets for both measures and determine the factorial structures of the AAS dependence Scale (AASDS) and AAS Craving Scale (AASCS). The AASDS consists of 15-items across five first-order factors that are represented by one second-order factor. The AASCS consists of 16-items across four first-order factors that are represented by one second-order factor. Evidence supporting the concurrent, convergent and discriminant validity of scores obtained with both scales was provided through their associations with the theoretically related variables. CFA with the data from Sample 2 confirmed the factor structures for both scales.
Conclusion: The AASDS and AASCS represent valid and reliable measures of AAS dependence and AAS craving for use in research with strength athletes who use AAS.

Keywords

References

  1. Med Sci Sports Exerc. 2006 Apr;38(4):644-51 [PMID: 16679978]
  2. Psychol Assess. 2019 Dec;31(12):1412-1427 [PMID: 30896212]
  3. Addiction. 2000 Aug;95 Suppl 2:S189-210 [PMID: 11002914]
  4. Addiction. 2001 Jan;96(1):33-46 [PMID: 11177518]
  5. J Stud Alcohol Drugs. 2008 Jul;69(4):496-9 [PMID: 18612564]
  6. Nebr Symp Motiv. 1986;34:257-323 [PMID: 3627296]
  7. Addiction. 2007 Jun;102(6):920-30 [PMID: 17523987]
  8. Drug Alcohol Rev. 2018 Jul;37(5):664-670 [PMID: 29484740]
  9. Psychother Psychosom. 2020;89(2):65-73 [PMID: 32066136]
  10. Am J Addict. 2014 Jul-Aug;23(4):371-7 [PMID: 24112239]
  11. J Consult Clin Psychol. 2004 Apr;72(2):192-201 [PMID: 15065954]
  12. Addiction. 2000 Aug;95 Suppl 2:S177-87 [PMID: 11002913]
  13. Sports Med. 1994 Nov;18(5):309-18 [PMID: 7871292]
  14. Alcohol Res Health. 1999;23(3):165-73 [PMID: 10890811]
  15. Nicotine Tob Res. 2013 Jul;15(7):1167-82 [PMID: 23291636]
  16. N Engl J Med. 2000 May 18;342(20):1532 [PMID: 10819660]
  17. Drug Alcohol Depend. 2009 Jun 1;102(1-3):130-7 [PMID: 19339124]
  18. NIDA Res Monogr. 1990;102:196-214 [PMID: 2079973]
  19. Addiction. 1995 May;90(5):607-14 [PMID: 7795497]
  20. Alcohol Clin Exp Res. 2001 Feb;25(2):299-308 [PMID: 11236847]
  21. Ann N Y Acad Sci. 2012 Feb;1248:1-17 [PMID: 22172057]
  22. Psychopharmacology (Berl). 2003 Apr;166(4):424-9 [PMID: 12605288]
  23. J Clin Psychiatry. 1989 Jan;50(1):31-3 [PMID: 2910837]
  24. Nicotine Tob Res. 2008 Mar;10(3):447-55 [PMID: 18324563]
  25. Addiction. 2000 Aug;95 Suppl 2:S155-63 [PMID: 11002910]
  26. J Consult Clin Psychol. 1996 Apr;64(2):366-79 [PMID: 8871421]
  27. Drug Alcohol Depend. 2020 Mar 1;208:107874 [PMID: 31972519]
  28. Mol Cell Endocrinol. 2018 Mar 15;464:46-55 [PMID: 28606866]
  29. Addiction. 2009 Dec;104(12):1966-78 [PMID: 19922565]
  30. Mayo Clin Proc. 2016 Feb;91(2):175-82 [PMID: 26769184]
  31. Psychol Rev. 1990 Apr;97(2):147-68 [PMID: 2186423]
  32. Med Hypotheses. 2009 Jun;72(6):723-8 [PMID: 19231088]
  33. Curr Psychiatry Rep. 2002 Oct;4(5):377-87 [PMID: 12230967]
  34. Am J Psychiatry. 2009 Jun;166(6):642-5 [PMID: 19487399]
  35. Drug Alcohol Depend. 2010 Jun 1;109(1-3):6-13 [PMID: 20188494]
  36. Pharmacotherapy. 2011 Aug;31(8):757-66 [PMID: 21923602]
  37. J Addict Dis. 2001;20(3):67-85 [PMID: 11681594]
  38. PLoS One. 2014 Sep 10;9(9):e105330 [PMID: 25207812]
  39. Drug Alcohol Depend. 1993 Dec;34(1):19-28 [PMID: 8174499]
  40. Drug Alcohol Depend. 2011 Mar 1;114(1):1-11 [PMID: 21115306]
  41. Am Psychol. 2016 Nov;71(8):670-679 [PMID: 27977239]
  42. Acta Psychol (Amst). 2000 Mar;104(1):1-15 [PMID: 10769936]
  43. Res Q Exerc Sport. 1993 Sep;64(3):256-73 [PMID: 8235047]
  44. Exp Clin Psychopharmacol. 2010 Jun;18(3):203-13 [PMID: 20545384]
  45. Addiction. 2005 Feb;100(2):227-34 [PMID: 15679752]
  46. Exp Clin Psychopharmacol. 1999 Nov;7(4):354-61 [PMID: 10609970]
  47. Sci Adv. 2019 Oct 09;5(10):eaax2084 [PMID: 31633021]
  48. Front Psychiatry. 2019 Aug 30;10:592 [PMID: 31543832]
  49. Drug Alcohol Depend. 2006 Jun 9;83(1):90-3 [PMID: 16310973]
  50. Drug Alcohol Depend. 2015 Mar 1;148:1-20 [PMID: 25637078]
  51. Psychol Addict Behav. 2006 Mar;20(1):91-6 [PMID: 16536671]
  52. Psychosomatics. 2005 Jul-Aug;46(4):285-90 [PMID: 16000671]
  53. Intern Emerg Med. 2009 Aug;4(4):289-96 [PMID: 19468827]
  54. Am J Mens Health. 2020 Nov-Dec;14(6):1557988320966536 [PMID: 33307930]
  55. Br J Addict. 1987 Jan;82(1):31-45 [PMID: 3470042]
  56. Drug Alcohol Depend. 2022 Feb 1;231:109275 [PMID: 35030506]
  57. Front Neurosci. 2015 Aug 26;9:295 [PMID: 26379484]
  58. Front Sports Act Living. 2022 Aug 01;4:903777 [PMID: 35979064]
  59. Addict Behav. 2018 Aug;83:123-129 [PMID: 29428330]
  60. Regul Toxicol Pharmacol. 2010 Jun;57(1):117-23 [PMID: 20153798]
  61. Br J Addict. 1991 Jun;86(6):759-68 [PMID: 1878625]
  62. Front Neuroendocrinol. 2008 Oct;29(4):490-506 [PMID: 18275992]

Word Cloud

Created with Highcharts 10.0.0AASdependencemeasurescravingusefactorSampleScalescalesathletesacrossAASDSAASCSassessadaptedspecificvaliditystrength1completednewinstrumentstheoreticallyrelatedDoping2CFAdatastructuresconsistsfirst-orderfactorsrepresentedonesecond-ordervalidationanabolic-androgenicsteroidsBackground:Anabolic-androgenicsteroidaffectsapproximately30%peoplePresentlydiagnoseformsdrugmisuseegalcoholcontainingissuesinternalconsistencybreadthconstructcaptureAdditionallyavailablerepresentspotentiallyimportantcoevalThereforestudyaimeddevelopprovideevidenceMethods:Datacollectedmalefemaletwosamples���=���206���=���224alongsideassessingconstructsMoralDisengagementSelf-RegulatoryEfficacyitemsWisconsinSmokingWithdrawalDiagnosticStatisticalManualMentalDisorder4EditionwhereasResults:ExploratoryConfirmatoryFactorAnalysesusedfinalizeitemsetsdeterminefactorialDependenceCraving15-itemsfive16-itemsfourEvidencesupportingconcurrentconvergentdiscriminantscoresobtainedprovidedassociationsvariablesconfirmedConclusion:representvalidreliableresearchDevelopmentdevelopment

Similar Articles

Cited By

No available data.